ABIN1 is a negative regulator of effector functions in cytotoxic T cells.
Sarka JanusovaDarina PaprckovaJuraj MichalikValeria UleriAles DrobekEva SalyovaLouise ChorfiAles NeuwirthArina AndreyevaJan ProchazkaRadislav SedlacekPeter DraberOndrej StepanekPublished in: EMBO reports (2024)
T cells are pivotal in the adaptive immune defense, necessitating a delicate balance between robust response against infections and self-tolerance. Their activation involves intricate cross-talk among signaling pathways triggered by the T-cell antigen receptors (TCR) and co-stimulatory or inhibitory receptors. The molecular regulation of these complex signaling networks is still incompletely understood. Here, we identify the adaptor protein ABIN1 as a component of the signaling complexes of GITR and OX40 co-stimulation receptors. T cells lacking ABIN1 are hyper-responsive ex vivo, exhibit enhanced responses to cognate infections, and superior ability to induce experimental autoimmune diabetes in mice. ABIN1 negatively regulates p38 kinase activation and late NF-κB target genes. P38 is at least partially responsible for the upregulation of the key effector proteins IFNG and GZMB in ABIN1-deficient T cells after TCR stimulation. Our findings reveal the intricate role of ABIN1 in T-cell regulation.
Keyphrases
- regulatory t cells
- signaling pathway
- type diabetes
- dendritic cells
- genome wide
- pi k akt
- multiple sclerosis
- cardiovascular disease
- cell proliferation
- oxidative stress
- single cell
- poor prognosis
- dna methylation
- inflammatory response
- heat shock
- immune response
- cancer therapy
- type iii
- small molecule
- drug delivery
- adipose tissue
- binding protein
- glycemic control
- anti inflammatory